Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy
Abstract Gao-Min Liu and Yao-Ming Zhang recently published a review entitled «Targeting FBPase is an emerging novel approach for cancer therapy» (Liu and Zhang in Cancer Cell Int 18:36, 2018). In this paper, the authors highlighted how the down regulation or inactivation of FBPase, a rate limiting e...
Main Authors: | Philippe Icard, Ludovic Fournel, Antoine Coquerel, Joseph Gligorov, Marco Alifano, Hubert Lincet |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-018-0676-y |
Similar Items
-
Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update
by: Philippe Icard, et al.
Published: (2021-06-01) -
Targeting FBPase is an emerging novel approach for cancer therapy
by: Gao-Min Liu, et al.
Published: (2018-03-01) -
Toward the Prediction of FBPase Inhibitory Activity Using Chemoinformatic Methods
by: Shuwei Zhang, et al.
Published: (2012-06-01) -
The independent prokaryotic origins of eukaryotic fructose-1, 6-bisphosphatase and sedoheptulose-1, 7-bisphosphatase and the implications of their origins for the evolution of eukaryotic Calvin cycle
by: Jiang Yong-Hai, et al.
Published: (2012-10-01) -
Characterization of the ferredoxin/thioredoxin system and its targets in Physcomitrella patens
by: Gütle, Desirée
Published: (2017)